Apogee Therapeutics IncNASDAQ:APGE
- LAST PRICE47.1300
- TODAY'S CHANGE (%)1.2700 (2.7693%)
- Bid / Lots29.0000/ 10
- Ask / Lots48.9600/ 1
- Open / Previous Close46.1700 / 45.8600
- Day Range
- 52 Week Range
- Volume238,494
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | APGE |
|---|---|---|
| 09:32 ET | 568 | 46.17 |
| 09:34 ET | 300 | 44.83 |
| 09:36 ET | 312 | 44.83 |
| 09:38 ET | 620 | 44.52 |
| 09:39 ET | 200 | 44.7 |
| 09:41 ET | 600 | 45.13 |
| 09:43 ET | 200 | 45.24 |
| 09:45 ET | 677 | 45.53 |
| 09:48 ET | 465 | 45.805 |
| 09:50 ET | 100 | 45.805 |
| 09:52 ET | 6309 | 45.805 |
| 09:54 ET | 1300 | 45.85 |
| 09:56 ET | 100 | 45.85 |
| 09:57 ET | 3636 | 46.275 |
| 09:59 ET | 610 | 46.275 |
| 10:01 ET | 1046 | 45.99 |
| 10:03 ET | 300 | 45.955 |
| 10:06 ET | 330 | 45.92 |
| 10:12 ET | 200 | 45.88 |
| 10:14 ET | 500 | 45.865 |
| 10:15 ET | 102 | 45.84 |
| 10:17 ET | 100 | 45.84 |
| 10:19 ET | 100 | 45.84 |
| 10:21 ET | 700 | 45.61 |
| 10:24 ET | 200 | 45.46 |
| 10:26 ET | 100 | 45.47 |
| 10:28 ET | 300 | 45.43 |
| 10:32 ET | 320 | 45.435 |
| 10:33 ET | 800 | 45.38 |
| 10:35 ET | 667 | 45.37 |
| 10:37 ET | 100 | 45.365 |
| 10:39 ET | 100 | 45.39 |
| 10:42 ET | 4303 | 45.36 |
| 10:44 ET | 100 | 45.4199 |
| 10:46 ET | 600 | 45.155 |
| 10:48 ET | 300 | 45.145 |
| 10:50 ET | 100 | 45.145 |
| 10:51 ET | 1056 | 45.03 |
| 10:53 ET | 1435 | 45.4 |
| 10:55 ET | 286 | 45.37 |
| 10:57 ET | 200 | 45.32 |
| 11:00 ET | 1274 | 45.595 |
| 11:02 ET | 200 | 45.6 |
| 11:04 ET | 200 | 45.6 |
| 11:06 ET | 300 | 45.61 |
| 11:08 ET | 200 | 45.465 |
| 11:09 ET | 300 | 45.34 |
| 11:13 ET | 100 | 45.14 |
| 11:15 ET | 4023 | 45.33 |
| 11:18 ET | 400 | 45.48 |
| 11:24 ET | 100 | 45.5 |
| 11:27 ET | 200 | 45.47 |
| 11:29 ET | 200 | 45.47 |
| 11:31 ET | 2039 | 45.205 |
| 11:33 ET | 300 | 45.36 |
| 11:36 ET | 1200 | 45.25 |
| 11:38 ET | 241 | 45.33 |
| 11:40 ET | 700 | 45.4 |
| 11:44 ET | 1723 | 45.36 |
| 11:45 ET | 2400 | 45.27 |
| 11:49 ET | 200 | 45.29 |
| 11:51 ET | 100 | 45.3 |
| 11:54 ET | 500 | 45.32 |
| 11:56 ET | 500 | 45.32 |
| 11:58 ET | 1500 | 45.37 |
| 12:00 ET | 1700 | 45.51 |
| 12:02 ET | 300 | 45.41 |
| 12:03 ET | 300 | 45.485 |
| 12:05 ET | 100 | 45.485 |
| 12:07 ET | 100 | 45.495 |
| 12:09 ET | 400 | 45.63 |
| 12:12 ET | 1217 | 46.03 |
| 12:14 ET | 2572 | 46.55 |
| 12:18 ET | 790 | 46.49 |
| 12:20 ET | 100 | 46.61 |
| 12:21 ET | 650 | 46.61 |
| 12:23 ET | 849 | 46.89 |
| 12:27 ET | 100 | 46.99 |
| 12:30 ET | 100 | 46.975 |
| 12:32 ET | 1049 | 46.96 |
| 12:34 ET | 900 | 47.26 |
| 12:36 ET | 100 | 47.0332 |
| 12:38 ET | 1640 | 47.05 |
| 12:39 ET | 1600 | 47 |
| 12:41 ET | 300 | 47.18 |
| 12:48 ET | 689 | 47.037 |
| 12:50 ET | 200 | 47.295 |
| 12:52 ET | 100 | 47.3 |
| 12:54 ET | 500 | 47.155 |
| 12:56 ET | 100 | 47.135 |
| 12:57 ET | 538 | 47.465 |
| 12:59 ET | 600 | 47.16 |
| 01:01 ET | 8310 | 47.04 |
| 01:06 ET | 200 | 47.005 |
| 01:10 ET | 100 | 47 |
| 01:12 ET | 100 | 47 |
| 01:14 ET | 200 | 47 |
| 01:15 ET | 507 | 46.995 |
| 01:19 ET | 240 | 46.985 |
| 01:21 ET | 200 | 46.98 |
| 01:24 ET | 426 | 47.17 |
| 01:26 ET | 100 | 47.275 |
| 01:28 ET | 100 | 47.12 |
| 01:30 ET | 400 | 47.1 |
| 01:32 ET | 239 | 47.21 |
| 01:37 ET | 600 | 47.09 |
| 01:39 ET | 100 | 47.21 |
| 01:46 ET | 200 | 47.05 |
| 01:48 ET | 200 | 47.15 |
| 01:50 ET | 300 | 47.19 |
| 01:55 ET | 1000 | 47.11 |
| 01:57 ET | 880 | 46.97 |
| 02:02 ET | 1030 | 46.96 |
| 02:08 ET | 400 | 46.94 |
| 02:09 ET | 100 | 46.96 |
| 02:11 ET | 196 | 46.88 |
| 02:13 ET | 200 | 46.875 |
| 02:15 ET | 1071 | 46.86 |
| 02:18 ET | 100 | 46.92 |
| 02:20 ET | 400 | 46.92 |
| 02:22 ET | 400 | 46.83 |
| 02:26 ET | 400 | 46.62 |
| 02:27 ET | 850 | 46.63 |
| 02:29 ET | 300 | 46.68 |
| 02:33 ET | 1400 | 46.78 |
| 02:38 ET | 290 | 46.85 |
| 02:40 ET | 200 | 46.83 |
| 02:42 ET | 200 | 46.82 |
| 02:44 ET | 200 | 46.79 |
| 02:45 ET | 217 | 46.79 |
| 02:47 ET | 764 | 46.76 |
| 02:49 ET | 200 | 46.89 |
| 02:54 ET | 200 | 46.86 |
| 02:58 ET | 400 | 46.79 |
| 03:00 ET | 480 | 46.76 |
| 03:02 ET | 500 | 46.745 |
| 03:05 ET | 100 | 46.745 |
| 03:07 ET | 465 | 46.8 |
| 03:09 ET | 949 | 46.8 |
| 03:14 ET | 100 | 46.87 |
| 03:20 ET | 200 | 46.84 |
| 03:25 ET | 100 | 46.81 |
| 03:27 ET | 406 | 46.89 |
| 03:32 ET | 1488 | 46.79 |
| 03:34 ET | 100 | 46.79 |
| 03:36 ET | 1484 | 46.81 |
| 03:38 ET | 100 | 46.81 |
| 03:39 ET | 300 | 46.87 |
| 03:41 ET | 100 | 46.795 |
| 03:43 ET | 1636 | 46.89 |
| 03:45 ET | 200 | 46.95 |
| 03:48 ET | 300 | 46.75 |
| 03:50 ET | 600 | 46.81 |
| 03:52 ET | 432 | 46.765 |
| 03:54 ET | 4456 | 46.865 |
| 03:56 ET | 2214 | 47.11 |
| 03:57 ET | 3812 | 47.12 |
| 03:59 ET | 4511 | 47.13 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Apogee Therapeutics Inc | 2.7B | -27.1x | --- |
Summit Therapeutics Inc | 2.7B | -2.5x | --- |
MoonLake Immunotherapeutics | 2.7B | -55.7x | --- |
CG Oncology Inc | 2.7B | -38.4x | --- |
Janux Therapeutics Inc | 2.4B | -35.3x | --- |
Merus NV | 2.6B | -15.1x | --- |
Company Information
Apogee Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and immunology (I&I) indications with high unmet need. Its advanced programs are APG777 and APG808, which are developed for the treatment of AD and COPD, respectively. APG777 is a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) targeting IL-13. APG808 is an SQ extended half-life mAb targeting IL-4Rα. Its earlier-stage programs, APG990 and APG222, utilize advanced antibody engineering to target OX40L and both IL-13 and OX40L, which are developed for the treatment of AD. APG990 is an SQ extended half-life mAb targeting OX40L for the treatment of AD. APG222 is one or more extended half-life SQ antibodies targeting both IL-13 and OX40L, which has the potential to improve outcomes in AD.
Contact Information
- Headquarters
- 221 Crescent St. Building 17, Suite 102bWALTHAM, MA, United States 02453
- Phone
- 650-394-5230
- Fax
- 302-655-5049
Executives
- Chairman of the Board
- Mark McKenna
- Chief Executive Officer, Director
- Michael Henderson
- Chief Financial Officer
- Jane Henderson
- Chief Medical Officer
- Carl Dambkowski
- Independent Director
- Jennifer Fox
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 56.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.74 |
Book Value | $7.86 |
P/E Ratio | -27.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
